Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 801581, 6 pages
http://dx.doi.org/10.1155/2013/801581
Research Article

Increased Risk of RSV Infection in Children with Down's Syndrome: Clinical Implementation of Prophylaxis in the European Union

1Department of Immunology, University Medical Centre Utrecht, 3508 AB Utrecht, The Netherlands
2Department of Pediatrics (Neonatal Division), McMaster University, Hamilton, ON, Canada L8S 4L8
3Division of Infectious Diseases, Department of Pediatrics, University Medical Centre Utrecht, P.O. Box 85090, 3508 AB Utrecht, The Netherlands

Received 26 March 2013; Accepted 13 June 2013

Academic Editor: Roberto Burioni

Copyright © 2013 Dianne van Beek et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. L. P. Bloemers, A. M. Van Furth, M. E. Weijerman et al., “Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis—a prospective birth-cohort study,” Pediatrics, vol. 120, no. 4, pp. e1076–e1081, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Kristensen, L. G. Stensballe, J. Bjerre et al., “Risk factors for respiratory syncytial virus hospitalisation in children with heart disease,” Archives of Disease in Childhood, vol. 94, no. 10, pp. 785–789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Zachariah, M. Ruttenber, and E. A. F. Simões, “Down syndrome and hospitalizations due to respiratory syncytial virus: a population-based study,” Journal of Pediatrics, vol. 160, no. 5, pp. 827.e1–831.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-O. Fjaerli, T. Farstad, and D. Bratlid, “Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993–2000: a population-based retrospective study,” BMC Pediatrics, vol. 4, article 25, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Megged and Y. Schlesinger, “Down syndrome and respiratory syncytial virus infection,” Pediatric Infectious Disease Journal, vol. 29, no. 7, pp. 672–673, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. B. A. Paes, I. Mitchell, A. Banerji, K. L. Lanctôt, and J. M. Langley, “A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice,” Canadian Respiratory Journal, vol. 18, no. 2, pp. e10–e19, 2011. View at Google Scholar · View at Scopus
  7. E. M. Connor, “Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants,” Pediatrics, vol. 102, no. 3 I, pp. 531–537, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. M. P. Frogel, D. L. Stewart, M. Hoopes, A. W. Fernandes, and P. J. Mahadevia, “A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis,” Journal of Managed Care Pharmacy, vol. 16, no. 1, pp. 46–58, 2010. View at Google Scholar · View at Scopus
  9. B. Paes, I. Mitchell, A. Li, and K. Lanctôt, “Respiratory hospitalizations and respiratory syncytial virus prophylaxis in special populations,” European Journal of Pediatrics, vol. 171, no. 5, pp. 833–841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. K. S. Anderson, V. M. Mullally, L. M. Fredrick, and A. L. Campbell, “Compliance with RSV prophylaxis: global physicians' perspectives,” Patient Preference and Adherence, vol. 3, pp. 195–203, 2009. View at Google Scholar
  11. A. Warren, J. M. Langley, W. Thomas, and J. Scott, “Optimizing the delivery and use of a new monoclonal antibody in children with congenital heart disease: a successful provincial respiratory syncytial virus prophylaxis program,” Canadian Journal of Cardiology, vol. 23, no. 6, pp. 463–466, 2007. View at Google Scholar · View at Scopus
  12. A. I. Eidelman, O. Megged, R. Feldman, and O. Toker, “The burden of respiratory syncytial virus bronchiolitis on a pediatric inpatient service,” Israel Medical Association Journal, vol. 11, no. 9, pp. 533–536, 2009. View at Google Scholar · View at Scopus
  13. M. O. Blanken, M. Rovers, J. M. Molenaar et al., “Respiratory syncytial virus and recurrent wheeze in healthy preterm infants,” New England Journal of Medicine, vol. 368, no. 19, pp. 1791–1799, 2013. View at Google Scholar
  14. B. L. P. Bloemers, A. M. Van Furth, M. E. Weijerman et al., “High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection,” Pediatric Infectious Disease Journal, vol. 29, no. 1, pp. 39–42, 2010. View at Publisher · View at Google Scholar · View at Scopus